openPR Logo
Press release

Macro and Microeconomic Factors Continue to Impact Bacterial Conjunctivitis Market During 2014 - 2020

11-30-2017 01:32 PM CET | Health & Medicine

Press release from: Transparency Market Research

Macro and Microeconomic Factors Continue to Impact Bacterial

Conjunctivitis also termed as pink eye in the United States and Madras eyes in India is caused due to infection or inflammation of the transparent membrane that covers the part of eyeball and inner surface of eyelids. The name Madras eye was originated in 20th century when adenovirus was discovered in India. Conjunctivitis is most commonly caused due to viral or bacterial infection, exposure to chemical or irritants or allergic reaction. Allergic conjunctivitis is known to be caused due to allergens such as cosmetic smoke, dust mites, pollen, perfumes and balsam of peru. Blurred vision, redness of eye, sensitivity to light, watering or itching of both the eyes, watery discharge from one or both the eyes and feeling of grittiness in one or both the eyes are the major symptoms witnessed in individuals suffering from conjunctivitis.

Report Overview and TOC @ https://www.transparencymarketresearch.com/bacterial-conjunctivitis-market.html

It is a highly contagious disease and is easily spread through sharing of objects like towel and poor washing of hands. The infection can also spread through sneezing or coughing. Thus, kids or adults diagnosed with pink eye are recommended not travel to public places for that period of time. However, conjunctivitis caused due to allergens (caused due to seasonal pollens, cosmetics and perfumes) or chemicals (chemicals, liquids such as furniture polish or bleach) are not contagious. Although, conjunctivitis caused by infections is highly contagious but it does not cause any serious health problem if diagnosed at an early stage. But, if the disease is left untreated then it can lead to permanent vision loss or other serious eye problem. Keratoconjunctivitis is a combination of conjunctivitis and inflammation of cornea while, blepharoconjunctivitis is a combination of inflammation of the cornea and conjunctivitis.

Request brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3771

Bacterial conjunctivitis is one of the major eye problem encountered worldwide and are caused by bacteria’s such as Moraxella and Chlamydia trachomatis. These bacteria’s are responsible for causing persistent conjunctivitis with higher level of redness. Similarly, Staphylococci and Streptococci are witnessed to cause non acute bacterial conjunctivitis. Moreover, bacteria’s such as β-hemolytic streptococci, Neisseria gonorrhoeae and Corynebacterium diphtheriae are other bacterias that are responsible for the production of membranes or psuedomembranes in bacterial conjunctivitis. Most of the cases of bacterial conjunctivitis are acute and self limiting and not a major cause of serious health problem however; due to its high prevalence the infection can have large impact on the society as individuals tend to miss their school or work. Thus, antibiotic, pills, ointment or eyedrops are given to clear the infection. Furthermore, if antibiotics are not showing proper response then swabs for bacterial culture are examined in the laboratories. Generally, fluoroquinolones, macrolides, amynoglycosides, phenicols are prescribed for the treatment of bacterial conjunctivitis. Similarly, tetracyclines or doxycycline are also prescribed for the treatment of infection caused due to Neisseria gonorrhoeae and Chlamydia trachomatis.

For Specific and Customized requirements @ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=3771

Conjunctivitis is an extremely common condition with high incidence and low prevalence. The disease can be treated on its own. Hence, exact estimate of epidemlology of this disease is a challenge. However, as per the statistics published by government authority in the U.S approximately 5 million cases of bacterial conjunctivitis are reported due to increasing number of bacterial infections. Moreover, the treatment of disease in the U.S. accounts for approximately USD 589 million annually. It has also been witnessed that out of all the causes of conjunctivitis, bacterial conjunctivitis account for more than 50% of the cases. Thus, rising incidences of bacterial infection would drive the growth of this market.

Allergan, Inc., Merck, Pfizer, Inc., Novartis and others are some of the major players operating in this market segment.

Pre Book full report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=3771<ype=S

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. 

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact Us

Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Macro and Microeconomic Factors Continue to Impact Bacterial Conjunctivitis Market During 2014 - 2020 here

News-ID: 839914 • Views:

More Releases from Transparency Market Research

Automotive Tinting Film Market to be Worth USD 7.5 Bn by 2035 - By Film Type / By Vehicle Type / By Application | U.S. • China • India • Germany
Automotive Tinting Film Market to be Worth USD 7.5 Bn by 2035 - By Film Type / B …
The global automotive tinting film market was valued at US$ 4.8 billion in 2024 and is projected to reach US$ 7.5 billion by 2035, expanding at a compound annual growth rate (CAGR) of 5.6% from 2025 to 2035. This steady growth reflects the increasing adoption of tinting films across passenger and commercial vehicles, supported by growing consumer awareness regarding comfort, safety, and vehicle preservation. Preview crucial insights and findings from our
Global Meat Substitutes Market Poised for Robust Growth, set to Reach 20,100.0 Mn by 2035 | Transparency Market Research
Global Meat Substitutes Market Poised for Robust Growth, set to Reach 20,100.0 M …
The global meat substitutes market is undergoing a rapid transformation, emerging as one of the most dynamic and fast-evolving segments within the global food industry. According to the latest industry analysis, the market was valued at US$ 7,532.3 Mn in 2024 and is projected to reach US$ 20,100.0 Mn by 2035, expanding at a healthy compound annual growth rate (CAGR) of 9.4% from 2025 to 2035. This strong growth trajectory
Wrist Dive Computer Market Outlook 2035: Global Market to Grow from US$ 258.6 Mn to US$ 436.9 Mn by 2035 at a CAGR of 4.9%
Wrist Dive Computer Market Outlook 2035: Global Market to Grow from US$ 258.6 Mn …
The global wrist dive computer market is steadily expanding as recreational and professional diving activities gain popularity worldwide. Valued at US$ 258.6 million in 2024, the market is projected to reach US$ 436.9 million by 2035, growing at a compound annual growth rate (CAGR) of 4.9% from 2025 to 2035. This growth reflects rising participation in scuba and freediving, increasing safety awareness among divers, and continuous innovation in wearable dive
NOR Flash Market Outlook 2035: Automotive Electronics-Driven Growth to US$ 11.5 Billion by 2035 at 7.8% CAGR
NOR Flash Market Outlook 2035: Automotive Electronics-Driven Growth to US$ 11.5 …
The global NOR Flash Market(https://www.transparencymarketresearch.com/nor-flash-market.html) was valued at US$ 2.6 Bn in 2024 and is projected to reach US$ 11.5 Bn by 2035, expanding at a compound annual growth rate (CAGR) of 7.8% from 2025 to 2035. This sustained growth trajectory reflects the rising importance of reliable, fast-boot, and high-endurance non-volatile memory in embedded systems. Unlike data-centric storage technologies, NOR Flash remains indispensable for code storage, firmware execution, and mission-critical

All 5 Releases


More Releases for Bacterial

Prominent Bacterial Conjunctivitis Market Trend for 2025: Innovative Eye Drops T …
What Are the Projected Growth and Market Size Trends for the Bacterial Conjunctivitis Market? The bacterial conjunctivitis market has grown steadily, projected to expand from $4.52 billion in 2024 to $4.76 billion in 2025, at a CAGR of 5.3%. Growth factors include rising bacterial infection cases, improved diagnostics, patient education programs, stringent regulatory frameworks, and physician training. The bacterial conjunctivitis market is projected to grow steadily, reaching $5.54 billion by 2029 at
Community-Acquired Bacterial Pneumonia Market
DelveInsight's "Community-Acquired Bacterial Pneumonia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Community-Acquired Bacterial Pneumonia, historical and forecasted epidemiology as well as the Community-Acquired Bacterial Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Community-Acquired Bacterial Pneumonia market report provides current treatment practices, emerging drugs, Community-Acquired Bacterial Pneumonia market share of the individual therapies, and current
Bacterial Conjunctivitis Drugs Market Report 2018: Segmentation by Disease Type …
Global Bacterial Conjunctivitis Drugs market research report provides company profile for Pfizer Inc., Novartis AG, F. Hoffmann-La Roche, Bayer Healthcare, Valeant Pharmaceutical International Inc., Perrigo Company Plc, Akorn Inc., Santen Pharmaceutical Co. Ltd., Allergan Plc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth
Bacterial Conjunctivitis Drugs Market: Rising Incidence of Ophthalmic Bacterial …
The U.S. market for bacterial conjunctivitis drugs has been declining sharply over the last few years. Analysts project the trend to continue in the coming years. In 2013, the market’s opportunity was valued at US$473.3 mn, which is likely to reduce to US$439.8 mn by 2024. In the coming years, the market will have to experience a patent cliff as the top U.S. brands of bacterial conjunctivitis drugs, such as
Bacterial Conjunctivitis Drugs Market Driven by Rising Incidence of Ophthalmic B …
The U.S. market for bacterial conjunctivitis drugs is extremely fragmented, leading to commensurate competition among players. The entry barriers faced by new players despite having good research and development capabilities, is lack of capital, Transparency Market Research (TMR) states in its new report on the U.S. market for bacterial conjunctivitis drugs. R&D involves huge costs and this limits the production. Mergers and acquisitions and other forms of strategic alliances can
02-07-2017 | Health & Medicine
TMR
Bacterial Conjunctivitis Drugs Market Driven by Rising Incidence of Ophthalmic B …
The U.S. market for bacterial conjunctivitis drugs has been declining sharply over the last few years. Analysts project the trend to continue in the coming years. In 2013, the market’s opportunity was valued at US$473.3 mn, which is likely to reduce to US$439.8 mn by 2024. In the coming years, the market will have to experience a patent cliff as the top U.S. brands of bacterial conjunctivitis drugs, such as